CN1973881A - Medicine for promoting blood circulation, dispersing blood clots, eliminating swelling and pain, and dispelling wind and wetness - Google Patents
Medicine for promoting blood circulation, dispersing blood clots, eliminating swelling and pain, and dispelling wind and wetness Download PDFInfo
- Publication number
- CN1973881A CN1973881A CN 200510126558 CN200510126558A CN1973881A CN 1973881 A CN1973881 A CN 1973881A CN 200510126558 CN200510126558 CN 200510126558 CN 200510126558 A CN200510126558 A CN 200510126558A CN 1973881 A CN1973881 A CN 1973881A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- pain
- wetness
- examples
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The medicine with the functions of promoting blood circulation to disperse blood clots, eliminating swelling and pain and dispelling wind and wetness is prepared with eight kinds of Chinese medicinal materials, including cochinchina cudrania root, cowherb seed, boston ivy, elderberry, clematis root, etc. and through sorting material, stoving, crushing and mixing. The medicine of the present invention is one kind of externally applied medicine and has high transdermal capacity, high treating effect, high curative effect and no toxic side effect. It is used in treating rheumatic arthritis, rheumatoid arthritis, protrusion of lumbar intervertebral disc, hyperosteogeny, scapulohumeral periarthritis, etc.
Description
One, technical field
The present invention relates to the medicine of a kind of blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain, expelling wind and removing dampness, be specifically related to external pulvis medicine with prepared from traditional Chinese medicines.
Two, background technology
Treat rheumatic arthritis, rheumatoid arthritis, prolapse of lumbar intervertebral disc at present, hyperosteogeny, scapulohumeral periarthritis, numb hand and foot, diseases such as traumatic injury, the normal western medicines such as piroxicam, diclofenac, prednisone, ibuprofen that adopt, be difficult to eradicate, take sx or disappearance behind the medicine, after the drug withdrawal, symptom also can occur, and cure rate is low; On the other hand, it is big to take the Western medicine side effect, hinders intestinal, stomach, liver, kidney.At present, the above-mentioned disease of the treatment by Chinese herbs of employing is also arranged, but because Chinese medicine preparation is unreasonable, curative effect is very little.
Three, summary of the invention
The objective of the invention is provides the medicine of a kind of blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain, expelling wind and removing dampness in order to overcome the deficiency of prior art, its good effect, cure rate height.
Pharmaceutical formulation of the present invention is according to deep theory of Chinese medical science, develops on test of many times, practical basis.Technical scheme of the present invention is: according to composition by weight, will: 6 parts of Stephania cepharatha Hayata, 12 parts of Radix Cudraniaes, 16 parts of Semen Vaccariae, 16 parts of Rhizoma Smilacis hypoglaucaes, 16 parts of QIANJINLONG, 16 parts of parthenocissuss, 20 parts of Ramulus Sambuci Williamsii and 20 parts of Radix Clematidis, after selecting materials, dry, pulverizing, cross 40 mesh sieves, mixing, quantitative package.
Principle of drug action of the present invention be with dredge, antiinflammatory, detoxifcation, spleen invigorating, to protect the liver kidney be means, in the logical venation of relaxing, suppresses swelling, promotes the damaged tissue reparation.Theory of Chinese medical science thinks that the capable then blood of gas is capable, and the stagnation of QI is blood stasis then.Medicine of the present invention can strengthen the QI and blood running, and unobstructed strengthening vital QI to eliminate pathogenic factors improves antiviral, the ability of clean function of human body environment, and realization prevents and treats the purpose of malignant change, and drug osmotic makes the toxin of people's human body lose protection in human body cell, reaches Detoxication.In addition, medicine of the present invention has the temperature compensation Liver and kidney, fills up marrow, YIN and YANG balance regulating, eliminating stagnation circulation of qi promoting, nourishing blood to tranquillize the mind, the effect that the kidney invigorating is returned to life from the nether world.
Using method: medicine of the present invention is a kind of medicine for external use, with 15-40 ℃ warm water with this drug powder (medicated powder) furnishing pasty state, be poured on the plastic foil, spread the back out and keep 4-8 millimeter thickness, stick, cover or encase with cotton soft object in the affected part, the thickness and the temperature that keep mass, remove about 50 minutes, the drug of topical application for the second time is 3 day time at interval, and the drug of topical application is for twice a course of treatment.
The advantage that clinical drug of the present invention uses is: forceful drug effect, and saturating property is strong, and therapeutic effect is good, and the cure rate height has no side effect to human body.
In order to prove the effect of medicine brilliance of the present invention, the present invention has done a large amount of clinical observations, now clinical experiment is disclosed as follows:
Select case
1, alternative is a rheumatic arthritis, rheumatoid arthritis, prolapse of lumbar intervertebral disc, hyperosteogeny, scapulohumeral periarthritis, numb hand and foot, traumatic injury patient.
2, age 28-68 year, male or female, contraindication in pregnancy.
The case diagnosis standard
The traditional Chinese medical science is debated knowledge and is formulated by national unified editing traditional Chinese medical science universities and colleges teaching material;
Doctor trained in Western medicine is formulated by national unified editing doctor trained in Western medicine universities and colleges teaching material.
Therapeutic scheme
1, case grouping: select case 860 examples, 430 examples are organized in treatment, matched group 430 examples.Wherein:
Rheumatic arthritis 220 examples that state of an illness sign is roughly the same, 110 examples are organized in treatment, matched group 110 examples;
Rheumatoid arthritis 176 examples that state of an illness sign is roughly the same, 88 examples are organized in treatment, matched group 88 examples;
Prolapse of lumbar intervertebral disc 120 examples that state of an illness sign is roughly the same, 60 examples are organized in treatment, matched group 60 examples;
Hyperosteogeny 96 examples that state of an illness sign is roughly the same, 48 examples are organized in treatment, matched group 48 examples;
Scapulohumeral periarthritis 92 examples that state of an illness sign is roughly the same, 46 examples are organized in treatment, matched group 46 examples;
Numb hand and foot 76 examples that state of an illness sign is roughly the same, 38 examples are organized in treatment, matched group 38 examples;
Traumatic injury 80 examples that state of an illness sign is roughly the same, 40 examples are organized in treatment, matched group 40 examples;
Medicine is formed:
6 parts of Stephania cepharatha Hayata, 12 parts of Radix Cudraniaes, 16 parts of Semen Vaccariae, 16 parts of Rhizoma Smilacis hypoglaucaes, 16 parts of QIANJINLONG, 16 parts of parthenocissuss, 20 parts of Ramulus Sambuci Williamsii and 20 parts of Radix Clematidis after selecting materials, dry, pulverizing, are crossed 40 mesh sieves, mixing, quantitative package.
Using method:
The treatment group: with 40 ℃ warm water with this drug powder (medicated powder) furnishing pasty state, be poured on the plastic foil, spread the back out and keep 4-8 millimeter thickness, stick in the affected part, cover or encase with the soft object of cotton, keep the thickness and the temperature of mass, remove about 50 minutes, the drug of topical application for the second time is 3 day time at interval, and the drug of topical application is for twice a course of treatment.
Matched group: conventional western medicine.
Efficacy evaluation
Efficacy assessment standard
1, recovery from illness: after finishing the course of treatment, symptom, sign disappear, and the laboratory leading indicator is recovered or be approaching normal.
2, produce effects: after finishing the course of treatment, symptom, sign disappear substantially, and the laboratory leading indicator also has clear improvement.
3, effective: after finishing the course of treatment, symptom, sign alleviate, and the laboratory leading indicator also has improvement.
4, invalid: after finishing the course of treatment, symptom, sign and other index do not have obvious improvement.
The efficacy evaluation result
There were significant differences for the two groups of total effectses in treatment back, treatment group total effective rate 96%, and cure-remarkable-effectiveness rate 80%, treatment group clinical effectiveness is apparently higher than matched group.
| Treatment group and matched group are always treated statistical table (course of treatment) | |||||||
| The example number | Recovery from illness | Produce effects | Effectively | Invalid | Cure-remarkable-effectiveness rate % | Total effective rate % | |
| The treatment group | 430 | 304 | 40 | 69 | 17 | 80 | 96 |
| Matched group | 430 | 158 | 130 | 82 | 60 | 67 | 87 |
Four, the specific embodiment
Will: 6 parts of Stephania cepharatha Hayata, 12 parts of Radix Cudraniaes, 16 parts of Semen Vaccariae, 16 parts of Rhizoma Smilacis hypoglaucaes, 16 parts of QIANJINLONG, 16 parts of parthenocissuss, 20 parts of Ramulus Sambuci Williamsii and 20 parts of Radix Clematidis, after selecting materials, dry, pulverizing, cross 40 mesh sieves, mixing, with 40 ℃ warm water with this drug powder (medicated powder) furnishing pasty state, be poured on the plastic foil, spread the back out and keep 4-8 millimeter thickness, stick in the affected part, cover or encase with the soft object of cotton, keep the thickness and the temperature of mass, remove about 50 minutes, the drug of topical application for the second time is 3 day time at interval, and the drug of topical application is for twice a course of treatment.
Claims (1)
1, the medicine of a kind of blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain, expelling wind and removing dampness, it is characterized in that according to composition by weight, will: 6 parts of Stephania cepharatha Hayata, 12 parts of Radix Cudraniaes, 16 parts of Semen Vaccariae, 16 parts of Rhizoma Smilacis hypoglaucaes, 16 parts of QIANJINLONG, 16 parts of parthenocissuss, 20 parts of Ramulus Sambuci Williamsii, 20 parts of Radix Clematidis, after selecting materials, dry, pulverizing, cross 40 mesh sieves, mixing, quantitative package.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005101265585A CN100391512C (en) | 2005-11-28 | 2005-11-28 | Medicine for promoting blood circulation, dispersing blood clots, eliminating swelling and pain, and dispelling wind and wetness |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005101265585A CN100391512C (en) | 2005-11-28 | 2005-11-28 | Medicine for promoting blood circulation, dispersing blood clots, eliminating swelling and pain, and dispelling wind and wetness |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1973881A true CN1973881A (en) | 2007-06-06 |
| CN100391512C CN100391512C (en) | 2008-06-04 |
Family
ID=38124415
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005101265585A Expired - Fee Related CN100391512C (en) | 2005-11-28 | 2005-11-28 | Medicine for promoting blood circulation, dispersing blood clots, eliminating swelling and pain, and dispelling wind and wetness |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100391512C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102068615A (en) * | 2010-12-14 | 2011-05-25 | 赵龙山 | Chinese medicinal liquid for treating sciatica |
| CN105079278A (en) * | 2015-05-17 | 2015-11-25 | 王兰英 | Traditional Chinese medicine composition for treating traumatic injury |
| CN105687321A (en) * | 2016-04-04 | 2016-06-22 | 沂水县润发柘树研究所 | Traditional Chinese medicine composition for treating rheumatism |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1150922C (en) * | 2001-02-21 | 2004-05-26 | 杨玉明 | Medicated wine for treating rheumatism, rheumatoid disease and other arthralgia |
| CN1217681C (en) * | 2002-04-26 | 2005-09-07 | 鲍自立 | Externally applied paste for treating fracture and injured tendons |
-
2005
- 2005-11-28 CN CNB2005101265585A patent/CN100391512C/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102068615A (en) * | 2010-12-14 | 2011-05-25 | 赵龙山 | Chinese medicinal liquid for treating sciatica |
| CN102068615B (en) * | 2010-12-14 | 2013-04-03 | 赵龙山 | Chinese medicinal liquid for treating sciatica |
| CN105079278A (en) * | 2015-05-17 | 2015-11-25 | 王兰英 | Traditional Chinese medicine composition for treating traumatic injury |
| CN105687321A (en) * | 2016-04-04 | 2016-06-22 | 沂水县润发柘树研究所 | Traditional Chinese medicine composition for treating rheumatism |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100391512C (en) | 2008-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100563690C (en) | A kind of medicine for the treatment of rheumatism, rheumatoid, puerperal exposure to wind, hyperosteogeny and disease of proplapse of lumbar intervertebral disc | |
| CN1343506A (en) | Chinese patent medicine for treating allergic dermatopathy | |
| CN1872180A (en) | Medication of membranous milk vetch for activating blood and the channels, and preparation method | |
| CN1907410A (en) | Chinese traditional medicine preparation for treating bone fracture and traumatic injury | |
| CN100391512C (en) | Medicine for promoting blood circulation, dispersing blood clots, eliminating swelling and pain, and dispelling wind and wetness | |
| CN1060391C (en) | Traditional Chinese medicine for treating gynecological tumour | |
| CN1843421A (en) | Rheumatoid disease treating medicine | |
| CN1074676C (en) | Medicine for treating rheumatic arthritis and hyperosteogeny and preparing process thereof | |
| CN1389255A (en) | Composite Chinese medicine for treating rheumarthritis and rheumatoid arthritis | |
| CN102755515B (en) | Traditional Chinese medicine decoction for treating hyperplasia of mammary glands | |
| CN1234385C (en) | Health-care medicinal plaster used for preventing and curing discopathy, osteosis, ischialgia | |
| CN101214365A (en) | Chinese medicine composing prescription for treating mastoproliferation | |
| CN1857636A (en) | Chinese medicine capsule for treating protrusion of intervertebral disc and hyperosteogeny | |
| CN1181878C (en) | Detumescence plaster | |
| CN1253196C (en) | Medicine for treating colitis | |
| CN1278706C (en) | Medicine for treating wind-dampness syndrome | |
| CN1899564A (en) | External use medicine for treating hyperosteogeny and protrusion of intervertebral disc | |
| CN103301215A (en) | Pharmaceutical composition for treating bone disease as well as preparation method and use thereof | |
| CN101732606B (en) | Oral medicinal composition for treating psoriasis | |
| CN100509003C (en) | Medicament of treating psoriasis | |
| CN1314409C (en) | Medicine for inhibiting and eliminating cancer | |
| CN1682858A (en) | Adhesive umbilicus powder for removing spot | |
| CN1054769C (en) | Chinese medicinal preparation for treatment of psoriasis and preparation method thereof | |
| CN101062340A (en) | Chinese traditional medicine combination good for liver for revovery | |
| CN1899597A (en) | Medicine for treating cold after delivery |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080604 Termination date: 20141128 |
|
| EXPY | Termination of patent right or utility model |